Lemonade, Inc. (NYSE:LMND) Insider Sells $1,500,000.00 in Stock

Lemonade, Inc. (NYSE:LMND) insider Maya Prosor sold 30,000 shares of the stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $50.00, for a total transaction of $1,500,000.00. Following the transaction, the insider now owns 29,286 shares of the company’s stock, valued at $1,464,300. This represents a 50.60 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Maya Prosor also recently made the following trade(s):

• On Monday, November 11th, Maya Prosor sold 20,000 shares of Lemonade stock. The shares were sold at an average price of $30.00, for a total transaction of $600,000.00.

Lemonade Stock Up 3.5 %

NYSE:LMND opened at $51.01 on Tuesday. The stock has a market cap of $3.64 billion, a P/E ratio of -16.78 and a beta of 1.68. The business’s 50-day moving average price is $23.64 and its two-hundred day moving average price is $19.78. Lemonade, Inc. has a twelve month low of $14.03 and a twelve month high of $53.85.

Lemonade (NYSE:LMND) last announced its earnings results on Wednesday, October 30th. The company reported ($0.95) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.02) by $0.07. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. The business had revenue of $136.60 million during the quarter, compared to analyst estimates of $129.10 million. During the same period in the previous year, the business posted ($0.88) earnings per share. Lemonade’s revenue for the quarter was up 19.3% on a year-over-year basis. On average, equities research analysts expect that Lemonade, Inc. will post -3.05 EPS for the current fiscal year.

Analyst Ratings Changes

LMND has been the topic of a number of analyst reports. Piper Sandler boosted their target price on shares of Lemonade from $25.00 to $44.00 and gave the company a “neutral” rating in a report on Thursday, November 21st. Jefferies Financial Group decreased their price objective on Lemonade from $15.00 to $14.00 and set an “underperform” rating on the stock in a research note on Wednesday, October 9th. Keefe, Bruyette & Woods downgraded Lemonade from a “market perform” rating to an “underperform” rating and raised their target price for the stock from $18.00 to $21.00 in a research note on Thursday, November 7th. Morgan Stanley upgraded Lemonade from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $23.00 to $42.00 in a research report on Wednesday, November 20th. Finally, BMO Capital Markets increased their price target on shares of Lemonade from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Thursday, November 21st. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $30.43.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Axiom Advisory LLC raised its position in Lemonade by 1.6% during the third quarter. Axiom Advisory LLC now owns 54,400 shares of the company’s stock valued at $897,000 after purchasing an additional 850 shares in the last quarter. Blue Trust Inc. lifted its position in Lemonade by 220.0% in the 3rd quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock worth $45,000 after buying an additional 1,879 shares during the last quarter. Van ECK Associates Corp boosted its stake in Lemonade by 12.1% in the second quarter. Van ECK Associates Corp now owns 17,774 shares of the company’s stock worth $293,000 after buying an additional 1,915 shares in the last quarter. Tidal Investments LLC boosted its stake in Lemonade by 4.6% in the third quarter. Tidal Investments LLC now owns 45,631 shares of the company’s stock worth $752,000 after buying an additional 2,017 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in Lemonade by 9.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 24,609 shares of the company’s stock valued at $404,000 after acquiring an additional 2,196 shares during the last quarter. 80.30% of the stock is currently owned by hedge funds and other institutional investors.

About Lemonade

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.